Please select the option that best describes you:
Topics:
Gastrointestinal Cancers • Medical Oncology
When do you use immunotherapy with MSI high advanced colorectal cancer?
does it matter whether it is given frontline vs later?
Answer from: Medical Oncologist at Academic Institution
Based on the available data from the KEYNOTE trials and CheckMate 142, I use immunotherapy in the second-line (or greater) setting. There is no data at this time to support front-line use, so I would only consider that for patients who are not good candidates for combination chemotherapy. KEYNOTE-17...
Sign in or Register to read more